Literature Review Indicates Efficacy of Obicetrapib in Treating Hyperlipidemia

5 months ago

A series of phase 2/3 trials collectively indicate the overall lipid-lowering effects of obicetrapib in a 5 mg dose, a 10 mg dose, and 10 mg with ezetimibe.

Source literature

↑

Literature Review Indicates Efficacy of Obicetrapib in Treating Hyperlipidemia

Related Article

Iranian Journal of "Countries Studies" Indexed in Int’l Scopus Database

Tasikmalaya Student Research Reaches the International Stage After Scopus Criticism

Guest post: In the name of Scopus, one hijacked journal easily tricks authors